Inhibition of Wnt/β‐catenin signaling downregulates P‐glycoprotein and reverses multi‐drug resistance of cholangiocarcinoma
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
The development of multi‐drug resistance (MDR) represents a major obstacle in the successful treatment of cancers. However, the factors and mechanisms that lead to MDR in cholangiocarcinoma (CCA), a chemoresistant bile duct carcinoma with a poor prognosis, remain unclear. In this study, we established a human MDR CCA cell line QBC 939/5‐FU. Compared with QBC 939 cells, a rounder shape, a higher nuclear–cytoplasmic ratio, a shorter cell cycle, faster growth and resistance to chemotherapeutics are major characteristics of QBC 939/5‐FU cells. P‐glycoprotein (P‐gp) and β‐catenin were upregulated in QBC 939/5‐FU cells. Furthermore, the drug susceptibility of QBC 939 cells to common chemotherapeutics was significantly decreased after Wnt3a treatment, whereas inhibition of Wnt/β‐catenin pathway by β‐catenin si RNA reversed the MDR of QBC 939/5‐FU cells to chemotherapeutics. Molecular study revealed that activation of Wnt/β‐catenin pathway resulted in upregulation of P‐gp and contributed to MDR of QBC 939/5‐FU cells. Extraction of Siamese Crocodile 3 (ESC‐3) bile enhanced the drug sensitivity of QBC 939/5‐FU cells to 5‐FU, paralleled with downregulation of β‐catenin and P‐gp. The association of Wnt/β‐catenin pathway and P‐gp was further confirmed by the clinical data for CCA tissues. Our study represents the first implication of Wnt/β‐catenin activation in the MDR of CCA, which may be a beneficial target for the clinical treatment of CCA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wnt/β-catenin signaling and disease
Clevers, H., & Nusse, R. (2012) · Cell · doi:10.1016/j.cell.2012.05.012 · Cited by 5,554
Multidrug resistance in cancer: role of ATP–dependent transporters
Gottesman, M. M., Fojo, T., & Bates, S. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc706 · Cited by 5,536
Cited by
Chen, Z., Shi, T., Zhang, L., Zhu, P., Deng, M., Huang, C., Hu, T., Jiang, L., & Li, J. (2016) · Cancer Letters · doi:10.1016/j.canlet.2015.10.010 · Cited by 729
New Horizons for Precision Medicine in Biliary Tract Cancers
Valle, J. W., Lamarca, A., Goyal, L., Barriuso, J., & Zhu, A. X. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0245 · Cited by 626
Wnt–β-catenin signalling in liver development, health and disease
Perugorria, M. J., Olaizola, P., Labiano, I., Esparza-Baquer, A., Marzioni, M., Marin, J. J. G., Bujanda, L., & Banales, J. M. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0075-9 · Cited by 605
Inhibition of the Multidrug Resistance P-Glycoprotein: Time for a Change of Strategy?
Callaghan, R., Luk, F., & Bebawy, M. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.056176 · Cited by 453
Ahmed Juvale, I. I., Abdul Hamid, A. A., Abd Halim, K. B., & Che Has, A. T. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e09777 · Cited by 190
“Both the PI3K/Akt/mTOR pathway [186, 187, 188] and Wnt/β-catenin signalling pathway [189, 190, 191] have also been shown to upregulate PGP”
Background
Metadata
- Authors
- Shen, D., Zhang, W., Zeng, X., & Liu, C.
- Venue
- Cancer Science
- Publisher
- Wiley
- Published
- 2013-08-06
- Volume
- 104
- Issue
- 10
- Pages
- 1303-1308
- ISSN
- 1347-9032 (ISSN-L)
- 1349-7006
- OpenAlex
- W2116535376
- Cited by
- 105
- References
- 2
- FWCI
- 4.27
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inhibition of Wnt/β‐catenin signaling downregulates P‐glycoprotein and reverses multi‐drug resistance of cholangiocarcinoma. https://app.cochat.ai/papers/10.1111/cas.12223
- The paper
- Shen, D., Zhang, W., Zeng, X., & Liu, C. (2013). Inhibition of Wnt/β‐catenin signaling downregulates P‐glycoprotein and reverses multi‐drug resistance of cholangiocarcinoma. Cancer Science. https://doi.org/10.1111/cas.12223
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.